investigational new drug (ind) submission: content/format and first 30 days (5of14) redi 2018
Published 4 years ago • 11K plays • Length 33:18Download video MP4
Download video MP3
Similar videos
-
46:00
introduction to investigational new drug (ind) applications (3/14) redi 2017
-
40:34
demystifying the investigational new drug (ind) application for drugs and biologics (3of14) redi '18
-
3:25
how to register an investigational new drug (ind) to the us fda
-
5:30
what is investigational new drug (ind) application? | regulatory learnings | drug regulatory affairs
-
36:51
investigational new drug safety reporting requirements (10of14) redi 2018
-
4:59
research investigational new drug applications – what you need to know
-
58:49
investigational new drug application (ind) forms: updates and best practices
-
2:03:01
investigational new drug workshop
-
36:55
components of new drug application and biologics license application (5of15) redi– may 29-30, 2019
-
1:15:32
webinar about us investigational new drug (ind) applications
-
40:53
submit your investigational new drug (ind) application and clinical holds (9/14) redi 2017
-
1:20
investigational new drug (ind) for us fda | phase 1 to 4 clinical trials services | drug development
-
11:47
preparing an ind application
-
2:10
how are cancer drugs approved?
-
40:24
fda communication during drug development (4/14) redi 2017
-
21:20
investigator responsibilities - safety reporting for investigational drugs and devices
-
9:53
complex innovative trial designs pilot meeting program: the process
-
1:48:00
clinical investigator training course (citc) update - operational updates part 1
-
8:24:45
regulatory education for industry (redi) annual conference 2022 - day 5